Novela Neurotech, a NeuroData company enabling personalized remote care for chronic neurological conditions, will showcase its nEureka® for Epilepsy smartwatch-based platform at the virtual Epilepsy Awareness Day at Disneyland (EADDL), November 2 at 9:30 AM PT.

Novela Neurotech, a Data-as-a-Service company developing personalized remote epilepsy care using connected consumer data, will showcase its neureka® for Epilepsy platform at the virtual CapCon 2020 Venture Conference, Sep 29 to Oct 1, 2020.

Research and development of new tools to fight and better understand seizures are critical aspects of our mutual goal to create a seizure-free world. We want to help organizations get your feedback and participation to shorten the time for those tools to get to market.

In mid-March, a trifecta of academic, non-profit, and commercial neurotech companies united to launch a neuroscientific challenge that embodied a more collaborative future for solving the brain, while physically apart and working from home.

Novela Neurotech is a spin off from a Canadian university, the University of Waterloo. We have a long track record of university research and development in what we call the field of neuromodulation, which is basically a way to alter brain functions through different modalities, such as using electricity to change the way brain cells communicate.

A researcher team from STADIUS: “Biomed Irregulars” won the first place in Neureka Challenge!!! Neureka challenge was a month-long challenge organized by Novela Neurotech and NeuroTechX on seizure prediction using the TUH EEG Seizure dataset (one of the biggest available seizure datasets).

As a highly experienced business strategic visionary leader, Dr. Abdel-Malek will support Novela in discovering dynaceutical therapies for brain disorders.

By partnering with INCF, one of the world’s largest institutions promoting data and software reuse and reproducibility in brain research, Novela positions itself as an industry leader in neuroscience data sharing and collaboration.

Alameda is known for many things—among them, the monthly antiques fair, the former Naval Air Station and the U.S.S. Hornet, spirits distilleries, a vintage pinball museum, and as the birthplace of popsicles and creamy peanut butter.

Novela Neurotech and NeuroTechX are teaming up in an effort to accelerate epilepsy research

The US-based startup Novela Neurotechnology builds Neureka, a smart platform to understand and decode neurological activity in the brain using artificial intelligence. Neureka, the startup’s platform combines smart neural interfaces and scheduled delivery of neuromodulation that results in accelerated drug discovery.

CRANIA, Novela Neurotech and Hahn-Schickard unites to accelerate the translation of Novela’s open source neuromodulation research kit.

Novela Neurotech teams up with UCSF to break down neurodata borders. Just as computer scientists developed standards to deliver digital content across the globe to your laptop, neuroscientists are working to break down barriers in data sharing.

Consciousness is one of the brain’s most enigmatic mysteries. A new theory, inspired by thermodynamics, takes a high-level perspective of how neural networks in the brain transiently organize to give rise to memories, thought and consciousness.

“Neurostimulation is emerging as a novel non-pharmacological way of treating brain disorders and is showing far greater efficacy with fewer side effects.”

Novela’s hometown newspaper the Alameda Sun featured us in their Thursday 1/24/19 issue “Novela’s long-term vision is to extend memory and brain processing speed, and even to add built-in cloud connectivity as well as expand human senses.”